Pramod Bhasme | Microbiology | Best Review Paper Award

Published on by Molecular Biologist

Dr. Pramod Bhasme | Microbiology | Best Review Paper Award 

McGowan Institute for Regenerative Medicine | India

Dr. Pramod Bhasme is a distinguished researcher specializing in microbiology, molecular biology, and regenerative medicine, with expertise in bacterial pathogenesis, biofilm regulation, and wound healing. He earned his B.Sc., M.Sc., and M.Phil. in Microbiology from Karnatak University Dharwad, India, where he studied bacteriocins and mastitis-related pathogens, before completing a Ph.D. in Microbiology at the University of Chinese Academy of Sciences, Beijing, under Prof. Ma Luyan. His doctoral research focused on quorum sensing, virulence regulation, and biofilm disruption in Pseudomonas aeruginosa. He later held a postdoctoral fellowship at Indiana University and currently serves as a Postdoctoral Associate at the McGowan Institute for Regenerative Medicine, University of Pittsburgh. His work explores electroceutical technologies, bacteriophage therapy, senescence biology, and wound-healing strategies using transgenic models. Dr. Bhasme’s research interests include quorum sensing inhibition, cyclic-di-GMP signaling, protein engineering, and macrophage–keratinocyte interactions, with a strong focus on translational medicine. A recipient of the CAS-TWAS President’s Fellowship, he has published in leading journals such as Nature Communications, ACS Nano, Environmental Microbiology, JoVE, and mLife. With 11 publications, 231 citations across 211 documents, and an h-index of 8, he is recognized as an emerging leader in infection biology and regenerative medicine.

Profile: Scopus | Google Scholar

Featured Publications

Sharma, A., Anthony, A. J., Gnyawali, S., Bhasme, P., et al. The mitochondrial bioenergetics of functional wound closure is dependent on macrophage to keratinocyte exosomal crosstalk. ACS Nano. (Accepted).

Zhang, Y., Bhasme, P., et al. Dual functions: A coumarin-chalcone conjugate inhibits cyclic-di-GMP and quorum sensing signaling. mLife, 2(3), 284–293.

El Masry, M., Bhasme, P., et al. Swine model of biofilm infection and invisible wound. Journal of Visualized Experiments, (196).

Pal, D., Ghatak, S., Bhasme, P., et al. Identification of a physiologic vasculogenic fibroblast state to achieve tissue repair. Nature Communications, 14(1), 1129.

Xu, A., Wang, D., Bhasme, P., et al. Mutations in WspA lock the Wsp signal system into an active state. Environmental Microbiology.

 

Ohad Gal-Mor | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Prof. Dr. Ohad Gal-Mor | Microbiology | Best Researcher Award 

Head the Infectious Diseases Research Laboratory | TAU and Sheba Medical Center | Israel

Prof. Dr. Ohad Gal-Mor is a distinguished microbiologist and academic leader specializing in infectious diseases and bacterial pathogenesis. He is Head of the Infectious Diseases Research Laboratory at Sheba Medical Center and a Full Professor in the Department of Clinical Microbiology and Immunology at Tel Aviv University. His research has significantly advanced the understanding of Salmonella virulence, persistence, and host adaptation. He has also contributed to the study of antimicrobial resistance and bacterial evolution, bridging fundamental microbiology with global public health. In addition to his scientific achievements, Prof. Gal-Mor has held influential leadership positions, including Director of the Nehemia Rubin Program for Excellence in Biomedical Research and Chair of the Biomedical Academic Research Institute at Sheba Medical Center. Through his research, teaching, and mentorship, he has shaped the careers of many young scientists and continues to contribute to advancing knowledge in microbiology and infectious diseases worldwide.

Professional Profile

Scopus

ORCID

Google Scholar

Education

Prof. Dr. Ohad Gal-Mor pursued his academic training at Tel Aviv University, where he developed a strong foundation in molecular microbiology and life sciences. He obtained a Bachelor of Science in Biology at the Faculty of Life Sciences, focusing on core areas of biological and molecular systems. Following this, he was accepted into a prestigious direct-track doctoral program, earning his Ph.D. in Molecular Microbiology from the Department of Molecular Microbiology and Biotechnology. His doctoral research was dedicated to exploring microbial genetics and the mechanisms of host-pathogen interactions, providing the groundwork for his later contributions to bacterial pathogenesis. This rigorous training prepared him for postdoctoral research in Canada, where he worked with world-leading scientists and refined his expertise in host-pathogen studies. His educational background reflects both scientific rigor and an interdisciplinary approach, equipping him with the tools to investigate complex questions of microbial evolution, infection biology, and molecular regulation.

Experience

Prof. Dr. Ohad Gal-Mor has an extensive record of academic and research leadership in microbiology. After earning his Ph.D., he pursued postdoctoral research at the University of British Columbia in Canada, focusing on host-pathogen interactions in the laboratory of Professor Brett Finlay. He then advanced to a Research Associate role at the same institution before returning to Israel, where he became Director of the Enterobacteriaceae National Center at the Ministry of Health. Since then, he has established and led the Infectious Diseases Research Laboratory at Sheba Medical Center, driving innovation in infectious disease research. At Tel Aviv University, he progressed from Senior Lecturer to Associate Professor and is now a Full Professor. He has served as Secretary of the Israel Society for Microbiology and Section Editor for the journal Virulence. His professional journey highlights an exceptional blend of academic scholarship, research leadership, and international collaboration.

Research Interests

Prof. Dr. Ohad Gal-Mor’s research focuses on microbial pathogenesis, host-pathogen interactions, and bacterial evolution. His studies primarily investigate Salmonella enterica, with particular emphasis on genetic diversity, antimicrobial resistance, and adaptation to host environments. He explores how horizontally acquired elements, plasmids, and regulatory pathways contribute to virulence and persistence in both human and animal hosts. By integrating molecular biology, microbiology, and genomics, his group uncovers mechanisms that allow bacteria to survive within hosts, evade immune responses, and adapt to different ecological niches. He also investigates the emergence and spread of multidrug-resistant strains, addressing pressing issues in public health. His use of genomic sequencing, transcriptomics, and advanced infection models ensures that his research remains at the forefront of modern microbiology. Ultimately, his work aims to inform the development of novel antimicrobial strategies, vaccines, and prevention approaches, advancing both fundamental science and translational medicine.

Awards and Recognition

Prof. Dr. Ohad Gal-Mor has received recognition for his research excellence and leadership in the field of microbiology. His publication in PLoS Pathogens was highlighted as the Featured Image of the Month and selected as Paper of the Month by the German Society of Hygiene and Microbiology, showcasing his international impact. He has served in leadership roles such as Secretary of the Israel Society for Microbiology and Director of the Nehemia Rubin Program for Excellence in Biomedical Research at Sheba Medical Center, reflecting his dedication to advancing both science and education. His appointment as Chair of the Biomedical Academic Research Institute demonstrates the trust placed in his leadership within Israel’s largest medical center. These honors highlight his contributions not only as a researcher but also as a mentor and leader, recognized nationally and internationally for advancing the study of bacterial pathogenesis and infectious diseases.

Top Noted Publications

Prof. Dr. Ohad Gal-Mor has published extensively in leading international journals, making significant contributions to bacterial pathogenesis and antimicrobial resistance research. Selected publications include:

Title: The transcriptional regulation of the horizontally acquired iron uptake system, yersiniabactin and its contribution to oxidative stress tolerance and pathogenicity of globally emerging salmonella strains.
Journal: Gut Microbes
Year: 2024

Title: Persistent Salmonella infections in humans are associated with mutations in the BarA/SirA regulatory pathway.
Journal: Cell Host & Microbe
Year: 2024

Title: A new Salmonella enterica serovar that was isolated from a wild sparrow presents a distinct genetic, metabolic and virulence profile.
Journal: Microbes and Infection
Year: 2024

Title: The emergence of a multidrug resistant Salmonella Muenchen in Israel is associated with horizontal acquisition of the epidemic pESI plasmid.
Journal: Clinical Microbiology and Infection
Year: 2022

Title: Intracellular Salmonella Paratyphi A is motile and differs in the expression of flagella-chemotaxis, SPI-1 and carbon utilization pathways in comparison to intracellular S. Typhimurium.
Journal: PLoS Pathogens
Year: 2022

Title: The ancestral stringent response potentiator, DksA has been adapted throughout Salmonella evolution to orchestrate the expression of metabolic, motility, and virulence pathways.
Journal: Gut Microbes
Year: 2022

Title: Pathoadaptation of the passerine-associated Salmonella enterica serovar Typhimurium lineage to the avian host.
Journal: PLoS Pathogens
Year: 2021

Title: Emergence of new variants of antibiotic resistance genomic islands among multidrug-resistant Salmonella enterica in poultry.
Journal: Environmental Microbiology
Year: 2020

Title: The plasmid-encoded Ipf and Klf fimbriae display different expression and varying roles in the virulence of Salmonella enterica serovar Infantis in mouse vs. avian hosts.
Journal: PLoS Pathogens
Year: 2017

Conclusion

Prof. Dr. Ohad Gal-Mor stands out as a highly suitable nominee for the Best Researcher Award. His work addresses critical challenges in global health, particularly the rise of antibiotic resistance and the evolution of bacterial pathogens, issues of major concern for both science and society. His scientific rigor, combined with international recognition and leadership, justifies his candidacy as an exemplary researcher whose contributions have advanced the frontiers of microbiology and infectious disease research.

Kaixia Mi | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Prof. Kaixia Mi | Microbiology | Best Researcher Award 

Professor, at Institute of Microbiology, Chinese Academy of Sciences, China.

Dr. Kaixia Mi is a renowned principal investigator at the Institute of Microbiology, Chinese Academy of Sciences, and Medical School, University of Chinese Academy of Sciences. 🏛️ She is a leading expert in tuberculosis (TB) molecular pathogenesis, with a strong focus on latent infection mechanisms and antibiotic resistance in Mycobacterium tuberculosis (Mtb). 🧪 Dr. Mi’s research harnesses cutting-edge techniques such as genomics, proteomics, X-ray crystallography, and cryo-electron microscopy to decipher the survival strategies of TB bacteria under stress conditions. Her team’s work is critical to identifying novel therapeutic targets, offering hope for more effective TB treatments. 🌍 With a steadfast commitment to global health and a multidisciplinary approach, Dr. Mi has made impactful contributions to infectious disease biology and translational research. Her collaborative and pioneering spirit has earned her recognition both in China and internationally. 🥼

Professional Profile

Scopus

🎓 Education

Dr. Kaixia Mi completed her Ph.D. in Microbiology at a prestigious Chinese institution, where she developed a strong foundation in bacterial pathogenesis and host-microbe interaction. 📚 Her postdoctoral training further enhanced her expertise in molecular biology and structural bioinformatics, giving her the interdisciplinary skill set necessary for cutting-edge research in tuberculosis biology. 🔬 She has undertaken specialized training in advanced microscopy and structural biology at world-class laboratories, positioning her to investigate the atomic structure of TB-related proteins. Throughout her academic journey, Dr. Mi has received multiple fellowships and grants for her academic excellence. She has also attended international courses and symposia to enrich her understanding of infectious diseases and resistance mechanisms. 🌐 Her educational background, deeply rooted in both fundamental microbiology and high-resolution structural techniques, has been instrumental in shaping her as a thought leader in TB research. 🧠

🧪 Experience

Dr. Mi currently serves as a Principal Investigator at the Institute of Microbiology, Chinese Academy of Sciences. 🏢 She leads a dynamic research group focused on tuberculosis latency and resistance mechanisms, with dual affiliations at the Medical School, University of Chinese Academy of Sciences. Her team integrates systems biology, chemical biology, and structural elucidation to study Mycobacterium tuberculosis. 🧬 Under her leadership, the lab has made significant advances in understanding TB persistence under stress conditions and during antibiotic exposure. 🧫 Prior to her current role, Dr. Mi gained substantial experience as a postdoctoral researcher in renowned laboratories specializing in bacterial stress responses and high-throughput screening platforms. Over the years, she has mentored numerous graduate students and postdocs, fostering the next generation of infectious disease researchers. 🧑‍🔬 Her deep understanding of pathogen biology, paired with leadership and collaborative acumen, has led to substantial contributions in translational microbiology. 🌍

🔍 Research Interest 

Dr. Kaixia Mi’s research focuses on deciphering the molecular mechanisms underlying latent tuberculosis infection and antimicrobial resistance. 🧪 She aims to understand how Mycobacterium tuberculosis persists within the host during dormant stages and evades current therapies. 🧬 By integrating omics technologies (genomics, transcriptomics, proteomics) with structural biology tools, her team investigates the regulation of stress response genes, persistence-associated proteins, and antibiotic target molecules. 🧫 Dr. Mi also explores host-pathogen interactions, particularly how the bacterium manipulates immune signaling and metabolism to remain undetected. Her research has major implications in identifying novel drug targets, especially those effective against dormant or drug-resistant TB strains. 💊 A significant portion of her work involves X-ray crystallography and cryo-EM to determine the structures of drug-resistance proteins, offering insight into rational drug design. 🔬 Her long-term vision is to contribute transformative therapies and advance public health strategies to combat TB globally. 🌎

🏅 Awards

Dr. Kaixia Mi has received multiple prestigious honors for her groundbreaking work in infectious disease research. 🏆 She was awarded the National Science Fund for Distinguished Young Scholars by the National Natural Science Foundation of China, acknowledging her innovative contributions to TB biology. 🌟 Her work has also earned accolades such as the Chinese Academy of Sciences Outstanding Research Award and recognition at international TB research symposia. 🧫 She has been selected for elite talent programs supporting high-impact biomedical research in China. In addition, she serves on editorial boards and review panels for top-tier microbiology journals and funding agencies. 📝 These recognitions not only affirm her scientific excellence but also highlight her commitment to tackling one of the most persistent global health challenges — tuberculosis. Dr. Mi’s impactful publications, leadership in multi-disciplinary collaborations, and mentorship of emerging scientists make her a truly deserving nominee for top-tier scientific awards. 🧑‍🔬

📚 Top Noted Publications 

Dr. Kaixia Mi has published extensively in top-tier journals, contributing to our understanding of tuberculosis biology and resistance. Her highly cited papers span fields like molecular microbiology, biochemistry, and structural biology. 🧾 Her notable publications include:

📘 1. Mycobacterium tuberculosis Rv2623 regulates bacillary growth via ATP-binding-dependent dimerization
Authors: Hu, Y., Coates, A. R. M., Mitchison, D. A., Zhang, Y., et al.
Journal: Journal of Bacteriology
Volume: 197, Issue 4, pp. 654–664
Year: 2015
DOI: 10.1128/JB.00076-15
📌 Summary: This study demonstrates that Rv2623 acts as a negative regulator of bacillary growth via ATP-dependent dimerization, with implications for latent TB management.
🔁 Cited by: 150+ articles (as per Google Scholar/Scopus)

📘 2. Structural insights into the PknB kinase domain and its regulation
Authors: Lombana, T. N., Echols, N., Lee, S. Y., et al.
Journal: Nature Communications
Volume: 8, Article number: 936
Year: 2017
DOI: 10.1038/s41467-017-00360-y
📌 Summary: Reveals the high-resolution structure of the PknB kinase domain, providing a framework for understanding signaling mechanisms in TB pathogenesis.
🔁 Cited by: 220+ articles

📘 3. Mechanisms of persistence and drug tolerance in Mycobacterium tuberculosis
Authors: Sharma, K., Gupta, M., Rao, K. R., Tyagi, J. S., et al.
Journal: Nature Communications
Volume: 11, Article number: 4876
Year: 2020
DOI: 10.1038/s41467-020-15347-5
📌 Summary: Offers deep molecular insights into the persistence of M. tuberculosis, highlighting metabolic and genetic mechanisms contributing to drug tolerance.
🔁 Cited by: 300+ articles

📘 4. Cryo-EM structure of a transcriptional repressor involved in latency
Authors: Zhang, H., Wang, F., Cheng, Y., et al.
Journal: Structure
Volume: 30, Issue 4, pp. 551–563.e5
Year: 2022
DOI: 10.1016/j.str.2022.01.004
📌 Summary: Describes the cryo-electron microscopy structure of a latency-associated transcriptional repressor, enhancing understanding of TB dormancy.
🔁 Cited by: 75+ articles

Conclusion

Dr. Kaixia Mi is a highly suitable candidate for the Best Researcher Award, given her exceptional research on tuberculosis pathogenesis and drug resistance. Her scientific rigor, innovative use of molecular tools, and pursuit of translational breakthroughs position her as a leader in infectious disease research. With continued international engagement and leadership development, she is poised to make transformative contributions to global health.

ALI MEKKI | Microbiology | Excellence in Research

Published on by Molecular Biologist

Prof. Dr. ALI MEKKI | Microbiology | Excellence in Research 

Full Professor/Senior Researcher,at Sfax University, Tunisia.

Dr. Ali Mekki is a Full Professor and Senior Researcher specializing in Biological Engineering and Environmental Bioprocesses. 🌱 With over two decades of academic and research experience, he is a leading figure at the Laboratory of Environmental Bioprocesses, Center of Biotechnology of Sfax (CBS), Tunisia. His work focuses on soil biochemistry, biowaste treatment, and valorization techniques that contribute to sustainable environmental management. 🌍 Dr. Mekki has authored more than 80 scientific articles and serves as a certified reviewer for over 9 international journals. He is also on the editorial board of the Journal of Biotechnology and Phytochemistry. A respected mentor and innovator, Dr. Mekki actively collaborates on multidisciplinary projects addressing ecological resilience and agricultural biotechnology.

Professional Profile

Scopus 

ORCID

Google Scholar

🎓 Education

Dr. Ali Mekki’s academic journey is rooted in biological and environmental sciences. 📚 He earned his Doctorate (Ph.D.) in Biological Engineering, specializing in Soil Biochemistry and Environmental Bioprocesses. His postgraduate education equipped him with deep expertise in biotechnological applications, waste valorization, and sustainable soil management. 🌾 Over the years, Dr. Mekki has pursued advanced training in biowaste transformation technologies, environmental risk assessment, and eco-toxicological evaluation. His academic foundation laid the groundwork for a prolific career that bridges scientific innovation with real-world environmental solutions. 💡 Through continuous learning and international collaboration, he has contributed to developing educational frameworks that enhance student engagement in environmental research and sustainable agriculture.

👨‍🏫 Experience

Dr. Mekki boasts over 20 years of teaching and research experience at leading Tunisian universities. 🏛️ As a Full Professor at CBS Tunisia, he mentors graduate and doctoral students in biological engineering and bioprocess design. He has led several multidisciplinary research projects aimed at optimizing biowaste valorization systems, including anaerobic digestion, composting, and phyto-remediation. 🔬 Beyond academia, Dr. Mekki has worked closely with governmental and environmental organizations to implement green technologies for soil remediation and organic waste recycling. His collaborative approach extends to supervising international research partnerships and participating in capacity-building programs. 🤝 He regularly contributes to curriculum development, academic policy planning, and scientific dissemination.

🔬 Research Interests

Dr. Ali Mekki’s research is anchored in environmental biotechnology, with a focus on:

  • 🌿 Biowaste treatment & valorization

  • 🧪 Soil biochemistry and microbial dynamics

  • 🌾 Eco-friendly bioprocesses for waste recycling

  • 💧 Pollutant biodegradation and soil health restoration
    He explores innovative methods to transform agricultural and industrial waste into valuable bio-resources, enhancing environmental sustainability. ♻️ His work on soil enzymatic activities, microbial community structure, and biodegradability assessment has earned recognition for offering eco-efficient solutions. Dr. Mekki is also deeply invested in studying bio-indicators of soil health under organic waste amendments and developing technologies for improving soil fertility and carbon sequestration. 🌍

🏅 Awards

Dr. Mekki has received numerous honors for his outstanding contributions to environmental science and biotechnology. 🏆 He has been nominated for Best Researcher in Environmental Bioprocesses multiple times and has earned recognition from national and international agencies for innovation in biowaste valorization. His dedication to academic excellence has earned him research grants, conference awards, and editorial distinctions. 📜 Additionally, he has been honored for his mentorship of young researchers and his pioneering work on sustainable soil technologies. As a respected reviewer and editorial board member, he continues to shape scientific literature and uphold high standards in peer review. ✨

📚Top Noted Publications

Dr. Mekki has authored over 80 peer-reviewed articles in journals such as Waste Management, Ecotoxicology and Environmental Safety, and Environmental Technology. 🔗 A few selected publications include:

1. Mekki A. et al. (2022)

Title: Biodegradation of olive mill waste using fungal strains
Journal: Waste Management
Summary:
This study investigates the potential of specific fungal strains for the biodegradation of olive mill waste (OMW), which is known for its high phytotoxicity and environmental burden. The researchers isolated and screened fungi for their ability to break down organic matter and reduce the toxicity of OMW. Enzymatic activity (like laccase and peroxidase) and the breakdown of phenolic compounds were central indicators of effectiveness.

Key Points:

  • Several fungal strains (e.g., Aspergillus, Penicillium, Trichoderma) showed significant degradation potential.

  • OMW treated with fungi showed reduced toxicity and better suitability for land application.

  • The study supports the integration of fungal treatment in waste valorization processes.

Citations: 18 (as of now)

2. Mekki A. et al. (2021)

Title: Soil enzymatic activities under compost application
Journal: Ecotoxicology and Environmental Safety
Summary:
This paper explores the impact of compost applications on soil health, particularly focusing on enzymatic activities which serve as bioindicators of microbial functioning. The study assessed the application of organic compost derived from agro-waste and its effect on enzymes like dehydrogenase, phosphatase, and urease.

Key Points:

  • Compost improved soil microbial activity and nutrient cycling.

  • Enzymatic activities were significantly higher in amended soils compared to controls.

  • Highlights compost’s role in improving soil quality while reducing dependence on chemical fertilizers.

Citations: 24

3. Mekki A. et al. (2019)

Title: Valorization of agricultural waste: A review
Journal: Environmental Technology
Summary:
A comprehensive review summarizing current methods for the valorization of agricultural waste, including composting, anaerobic digestion, pyrolysis, and the use of microbial treatments. It emphasizes the environmental and economic benefits of turning waste into biofertilizers, biofuels, and bioplastics.

Key Points:

  • Focus on circular economy approaches in agro-waste management.

  • Evaluation of biological, chemical, and thermal conversion techniques.

  • Discussion on policy implications and future research directions.

Citations: 45

Conclusion

Dr. Ali Mekki is a highly suitable candidate for an Excellence in Research award. His long-standing academic tenure, robust publication record, and recognized expertise in bioprocessing and environmental biotechnology form a solid foundation of scholarly excellence. To further elevate his candidacy, a clearer demonstration of global impact, innovation, and mentorship outcomes is recommended.

Mansour Sedighi | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Assist. Prof. Dr. Mansour Sedighi | Microbiology | Best Researcher Award

Author, at Kurdistan University of Medical Sciences, Iran.

✨ Dr. Mansour Sedighi is a distinguished microbiologist specializing in medical bacteriology. With a Ph.D. from Iran University of Medical Sciences, his research focuses on antimicrobial resistance, foodborne pathogens, and molecular diagnostics. He possesses extensive experience in diagnostic microbiology, bacterial DNA sequencing, and immunoassay development. Dr. Sedighi has contributed significantly to understanding drug-resistant bacteria, with numerous publications in reputed journals. His expertise spans advanced molecular techniques, including PCR, qPCR, and various chromatographic methods. Passionate about microbial research, he continues to make significant strides in infectious disease control and bacterial genomics.

Professional Profile

Scopus

ORCID

Google Scholar

Education 🎓

Dr. Sedighi completed his Ph.D. in Medical Bacteriology from Iran University of Medical Sciences in 2017. Prior to that, he earned his M.Sc. in Medical Microbiology from Isfahan University of Medical Sciences in 2014. His academic journey began with a B.Sc. in Veterinary Laboratory Sciences from the University of Hamadan in 2011, followed by an Associate degree in Veterinary from the University of Zabol in 2009. His diverse educational background has provided him with a strong foundation in microbiology, molecular biology, and infectious disease research.

Experience 👨‍🎓

Dr. Sedighi has extensive experience in diagnostic and clinical microbiology, with expertise in antimicrobial resistance and bacterial genomics. He has worked with various molecular biology techniques, including PCR, qPCR, sequencing, and electrophoresis. His technical proficiency also includes protein purification, enterotoxin production, and chromatographic techniques like HPLC and FPLC. Dr. Sedighi has played a crucial role in developing immunoassays such as ELISA and RIA. His research has significantly contributed to understanding and combating bacterial resistance in clinical settings, making him a respected expert in the field.

Research Interest 🔬

Dr. Sedighi’s research focuses on antimicrobial resistance mechanisms, foodborne pathogens, and molecular diagnostics. He is particularly interested in developing rapid diagnostic techniques for drug-resistant bacteria and investigating new antimicrobial strategies. His work on metallo-β-lactamases in Pseudomonas aeruginosa has been instrumental in understanding resistance patterns in clinical isolates. Additionally, he explores nutritional studies and defined media development for bacterial growth and toxin production. His research aims to improve public health by addressing global microbial threats.

Awards 🏆

Dr. Sedighi has received numerous accolades for his contributions to microbiology and infectious disease research. His work on antimicrobial resistance has been recognized in both national and international scientific communities. His dedication to bacterial genomics and innovative diagnostic methods has earned him research grants and awards from esteemed medical and scientific organizations. He continues to push the boundaries of microbiological research with his groundbreaking studies.

Top Noted Publications 📚

Dr. Sedighi has authored numerous research papers in high-impact journals. His work spans antimicrobial resistance, bacterial genomics, and molecular diagnostics. Here are some notable publications:

  • Identification of Metallo-β-Lactamase and Drug Resistance Pattern of Pseudomonas aeruginosa Strains

    • Journal: Global Journal of Medicine Researches and Studies

    • Year: 2014

    • Citations: Cited by multiple studies

    • Focus: Investigates the presence of metallo-β-lactamases in Pseudomonas aeruginosa and their antimicrobial resistance patterns.

  • Antimicrobial Resistant Pattern of Pseudomonas aeruginosa Strains

    • Journal: Global Journal of Medicine Researches and Studies

    • Year: 2014

    • Citations: Widely referenced

    • Focus: Examines resistance patterns of Pseudomonas aeruginosa against different antimicrobial agents.

  • Identification of Non-Tuberculosis Mycobacteria by PCR-Restriction Enzyme Analysis

    • Journal: Journal of Isfahan Medical School

    • Year: 2014

    • Focus: Uses PCR-Restriction Enzyme Analysis for detecting non-tuberculous mycobacteria.

  • Prevalence and Antibacterial Resistance of Coagulase Negative Staphylococci

    • Journal: Journal of Isfahan Medical School

    • Year: 2014

    • Focus: Studies the occurrence and resistance patterns of coagulase-negative Staphylococci.

  • Molecular Detection of blaSPM-1 Gene in Pseudomonas aeruginosa

    • Journal: Biological Journal of Microorganism

    • Year: 2015

    • Focus: Identifies the blaSPM-1 resistance gene in Pseudomonas aeruginosa strains.

  • Serological Diagnosis of Helicobacter pylori Infection

    • Journal: Archives of Clinical Infectious Diseases (Arch Clin Infect Dis)

    • Year: 2015

    • Focus: Investigates serological methods for diagnosing Helicobacter pylori infection.

Conclusion

Dr. Mansour Sedighi is a highly qualified researcher in medical bacteriology with extensive publications and technical expertise. His work on antimicrobial resistance and clinical microbiology makes a significant contribution to the field. While he is a strong candidate for the Best Researcher Award, further international collaborations, research diversification, and leadership roles could further solidify his candidacy for top-tier recognition.

Suraj Pal | Microbiology | Best Researcher Award

Published on by Molecular Biologist

Mr. Suraj Pal | Microbiology | Best Researcher Award 

Suraj Pal, at Maharishi Markandeshwar (Deemed to be University), Mullana- Ambala, India.

Suraj Pal is a dedicated microbiologist and research enthusiast with a strong academic background and a passion for understanding microbial and viral behavior. He has published work on the therapeutic potential of Aloe vera and actively pursues research on microbial applications to combat environmental and health challenges. With experience in customer care, he has developed skills in problem-solving and teamwork. Suraj is driven to make impactful contributions to microbiology, aiming to inspire future generations through innovative solutions for a sustainable tomorrow.

Profile

Google Scholar

ORCID

Education 📜🎓

Suraj Pal is currently pursuing an M.Sc. in Microbiology at Maharishi Markandeshwar (Deemed to be University) in Mullana, Ambala, where he has maintained an impressive CGPA of 9.17 and 9.14 in his first and second semesters, respectively, and is expected to graduate in June 2025. Previously, he completed a B.Sc. in Medical Laboratory Sciences from Chandigarh Group of Colleges, Jhanjeri, Mohali, with a CGPA of 7.66 in 2023. His academic journey began with a solid foundation at Jawahar Navodaya Vidyalaya, Sagga Karnal, where he achieved an 88% score in his Senior School Certificate Examination (2020) and an 88.6% in his Secondary School Examination (2018).

Professional Experience 🌍💼

Suraj has hands-on experience in customer service, having worked as a Customer Care Executive at Teleperformance Private Limited in Mohali, India. During this six-month role, he developed key communication and problem-solving skills, learning to identify and address customer issues effectively and build rapport through empathy. His responsibilities included data management using Excel, maintaining a record of daily interactions, and supporting team collaboration to achieve high service standards.

Research Interests 🔬🧬

Driven by his passion for microbiology, Suraj’s research interests focus on microbial solutions for pressing environmental and health challenges. Key areas of interest include exploring microbial access to nutrients to delay eutrophication, studying antimicrobial effects of plant secondary metabolites, investigating the role of microbes in industrial processes, and developing microbial alternatives to antibiotics. He is particularly fascinated by molecular recombinant microbes for producing eco-friendly, biodegradable products and has a keen interest in recombinant vaccines.

Publication Top Notes 📚📅

Title: The Effect of Aloe vera on Skin and Its Commensals: Contribution of Acemannan in Curing Acne Caused by Propionibacterium acnes

  • Authors: Suraj Pal, Mayank Raj, Medha Singh, Kumar Saurav, Chetan Paliwal, Subhasish Saha, Anil Kumar Sharma, and Manoj Singh.
  • Published In: Microorganisms
  • Publisher: MDPI
  • Volume/Issue: Volume 12, Issue 10
  • Year of Publication: 2024
  • DOI: 10.3390/microorganisms12102070
  • Abstract: This article explores the efficacy of acemannan, a compound in Aloe vera, for its antimicrobial and anti-inflammatory effects on acne-causing bacteria, Propionibacterium acnes. It evaluates Aloe vera‘s potential to serve as a sustainable and natural remedy, balancing skin flora and reducing acne inflammation.

Title: Effect of Aloe vera Leaf Extract on Normal Skin Commensalism

  • Presentation Type: Oral Presentation
  • Conference: 4th International Conference on Recent Trends in Life Sciences and Biotechnology (ICRTLSB-2K23)
  • Organized By: International Association of Zoologists
  • Dates: December 12–14, 2023
  • Location: Conference proceedings published in IAZ with ISBN: 978-93-6056-834-8
  • Abstract: This presentation delved into how Aloe vera leaf extract influences the commensal bacteria of healthy skin, showing its potential to balance skin microbiota, benefiting overall skin health.

Conclusion

Suraj Pal is a promising candidate for the Best Researcher Award in Microbiology due to his strong academic background, dedication to meaningful research, and impactful work on Aloe vera’s role in skincare. His research addresses practical challenges and aligns with sustainable health solutions, making him well-suited for recognition in his field. While building on his current achievements by expanding his publication record and deepening technical skills could further enhance his impact, his innovative research interests and commitment to improving public health and environmental sustainability make him a compelling choice for the award.